Julie Reygner, Johanne Delannoy, Marie-Thérèse Barba-Goudiaby, Cyrielle Gasc, Benoît Levast, Enora Gaschet, Laurent Ferraris, Stéphane Paul, Nathalie Kapel, Anne-Judith Waligora-Dupriet, Frederic Barbut, Muriel Thomas, Carole Schwintner, Bastien Laperrousaz, Nathalie Corvaïa
Growing evidence demonstrates the key role of the gut microbiota in human health and disease. The recent success of microbiotherapy products to treat recurrent Clostridioides difficile infection has shed light on its potential in conditions associated with gut dysbiosis, such as acute graft-versus-host disease, intestinal bowel diseases, neurodegenerative diseases, or even cancer. However, the difficulty in defining a "good" donor as well as the intrinsic variability of donor-derived products' taxonomic composition limits the translatability and reproducibility of these studies...
April 23, 2024: Applied and Environmental Microbiology